Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer
NCT03548285
Glottic Carcinoma
Dallas, Texas, United States
View Trial DetailsNCT Number: NCT04447456
Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outcome at 5 years of these two types of management in order to define whether one is superior to the other on this criterion of voice quality after treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Centre Oscar Lambret, Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: At 5 years
The VHI is a self-administered questionnaire that provides a score ranging from 0 to 120 points validated in France and internationally based on the declarative answers to 30 items of the questionnaire. A high score corresponds to a voice felt to be of poor quality. This is a subjective assessment made by the patient.
Time frame: At 5 years
The TMP is the measurement in seconds of a vowel (/a/) held for as long as possible.
Time frame: At 5 years
This score is obtained from an internationally and nationally validated hetero-assessment. It consists in the attribution by a listening jury made up of two people of a mark ranging from 0 to 3 for each of the 6 items: Grade, Roughness, Breathiness, Asthenia, Strain, Instability.
A high score is associated with a voice perceived as bad by the audience.
Time frame: At 5 years
short recording of the patient's voice delivering a standardized speech on VOCALAB software validated by the scientific community.
University Hospital, Lille
Other
Acronym: VO Qual
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03548285
Glottic Carcinoma
Dallas, Texas, United States
View Trial DetailsNCT07391345
Glottic Carcinoma, Head and Neck Neoplasms
Kaunas, Lithuania
View Trial DetailsNCT04908696
Glottic Carcinoma, Head and Neck Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT05688488
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Shanghai, Shanghai Municipality, China
View Trial Details